Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease - Wikidata - wikimedia - TriplyDB

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

http://www.wikidata.org/entity/Q26995276

about

Clearance systems in the brain-implications for Alzheimer disease Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease Lithium and autophagy Blood biomarkers for brain injury: What are we measuring?A Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging?Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells The Dynamics and Turnover of Tau Aggregates in Cultured Cells: INSIGHTS INTO THERAPIES FOR TAUOPATHIES.Designing of dual inhibitors for GSK-3β and CDK5: Virtual screening and in vitro biological activities study Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury.Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.Time dynamics of protein complexes in the AD11 transgenic mouse model for Alzheimer's disease like pathology.Neuropathology of Beta-propeller protein associated neurodegeneration (BPAN): a new tauopathy Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer's Disease.Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.Role of Endolysosomes in Skeletal Muscle Pathology Observed in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease.Involvement of inhibitory PAS domain protein in neuronal cell death in Parkinson's disease.In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein "Tau oligomers," what we know and what we don't know.Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders Tau-induced neurodegeneration: mechanisms and targets.Autophagy in Alzheimer's disease.Genes associated with Parkinson's disease: regulation of autophagy and beyond.Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer's Disease.Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation.Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions.Aquaporin-4 and Alzheimer's Disease.Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons.Non-parametric Survival Analysis of EPG5 Gene with Age at Onset of Alzheimer's Disease.LRRK2 Promotes Tau Accumulation, Aggregation and Release.Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD.The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties."Tau immunotherapy: Hopes and hindrances".Biological evaluation and energetic analyses of novel GSK-3β inhibitors.Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.A preclinical perspective on the enhanced vulnerability to Alzheimer's disease after early-life stress.iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia

P2860

Q26801541-434A5836-60F7-46B8-88C0-C9D805A58945 Q26853610-0F9E369A-20DB-4432-B83D-60DB8DFA6E8A Q26863513-458BC510-BF3B-4B6D-A6F2-FD861F19F2C7 Q28067275-878B1D36-9A78-4808-89C9-C824A617AC5E Q28078724-796A4102-B6C3-43C6-BA1E-5E918AA7923E Q28597082-7B61FF22-2DCF-4967-9FB7-98A174E9F81D Q30780758-9DC7AA55-7C05-4099-B984-37F7D82B43DE Q33566835-0527AF32-6B94-4083-9CDF-C323E4D4B7AC Q34540333-12EEC9C3-5222-40B4-9738-E7DD1F0E57CE Q34614529-1EBD3A7F-19F8-4DD6-9FCD-D92F87E290B1 Q35152946-65545742-10EB-4DDE-8430-DEC949EB6A00 Q35618276-5C62E1BD-64B5-4D1B-822F-EE4F86E35DF7 Q35802324-9ECFFF61-087C-4F92-94D4-27FBCA147A90 Q35894510-B93DE615-ADDA-4892-8B42-8228EEFB4C60 Q36484413-F739E045-4859-4949-8535-B3A21FBCAE7C Q36639242-D872A6EB-A9CE-4CEF-BDEB-EFC193C4823F Q36978700-F950DBB6-7BF6-4DEC-AC64-69BEBB600B15 Q37167475-EC365339-0481-4E48-BDFE-026839424D71 Q37284771-7EDF9A7C-163F-4EAE-958B-9AC7DD4BFF5C Q37467443-F57C014B-9A15-4D80-9D80-308ACEEAE5BA Q37710177-A82C9DE5-1A55-4950-A252-2AD0CEFC5686 Q38204720-CCA961A8-2DCE-407C-8ADA-CBFCC6F835F5 Q38419936-C01B972C-10B1-4C44-B9B2-EDC6304A046D Q38557027-1A5E46E2-1FB0-4F59-B00F-199D740958B5 Q38592263-30EF65BB-CFD5-4EAE-B4D0-B65FD46870F8 Q38684346-C5212837-1FD4-4F73-992E-638DBC53D0F7 Q38752185-40D9990B-5318-497C-AF2F-D046852EEED1 Q38794461-07703F5B-690C-4DAC-A982-6E7E93FB62E8 Q38849708-DBB81D94-5E66-4125-ACC5-EA7568AEBCC4 Q39431124-17143930-2787-4F8C-ADB8-5F9272335832 Q40899192-94BA90EB-BA93-4FB1-A7A3-740263046E6F Q43115550-3A2D82FF-CEAF-42BE-9228-225CFB8E3F46 Q46669000-8FFFE586-4844-4181-B95C-7B77FBFBA234 Q47629452-53C5A1C7-06DE-412C-BD7B-C56269CEA071 Q47836876-8DC3E0F7-836C-4F9E-9C02-C3208E1C82A8 Q47887763-6FDEF36F-211F-43B1-83E3-A18FA3215A51 Q49166910-B3C8257F-9C17-4BFD-B245-7B00EFA872FE Q52598834-FA335B7B-642E-4397-86BD-2F8055E83DB5 Q55283322-F6818F4D-8F8F-4B8E-A9DD-03C33BC3766F Q59133545-CF8E2D47-401D-41AF-9C88-DFC1E72FC19F

P2860

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

http://www.wikidata.org/entity/Q26995276

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

@ast

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

@en

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

@nl

type

label

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

@ast

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

@en

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

@nl

prefLabel

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

@ast

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

@en

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

@nl

P1433

Q26995276-E7047489-D6F8-4611-A503-8F4D3661E9C2

P1476

Q26995276-BF59AB68-568F-4F73-8DEF-5A78C7DE356A

P2093

Q26995276-0C753C4C-07A9-4985-BB9D-85F1297E7EBB

Q26995276-860E481C-A33C-4DB3-A1ED-367B329F33DD

Q26995276-AD45F421-BC6A-447B-9DD5-D88FA1227FF3

P2860

Q26995276-004C42B3-B776-4643-85FE-5E29555767C8

Q26995276-0079C44D-F8C0-413D-961D-A8255C46FA0F

Q26995276-03ADDD67-71EB-4346-9D2E-F91B064AD7A8

Q26995276-03CD2FB9-7FD9-4D98-8C6F-9113992914A9

Q26995276-06557DA8-7827-4894-931A-42073AD5867E

Q26995276-07A4A1BD-C38C-48D0-863E-B2D740060068

Q26995276-082A5618-4005-4515-9AD4-0E9162BA4507

Q26995276-11CF7B06-00A4-493E-8764-EFB4D0F8A7AB

Q26995276-1306DDDE-41B4-49C8-99EB-16A494696B76

Q26995276-132B429C-CE02-49A6-B727-F32AB2A40CDE

P304

Q26995276-EB77D79C-20BB-43A7-9120-9E8FEB0BC43D

P31

Q26995276-A617242E-F4BE-49FA-B94F-48E6178C65AE

P3181

Q26995276-7D58056B-F4EE-401C-B186-10668E77EA4B

P356

Q26995276-E2DAF92C-B586-4379-842C-55192C45E49B

P407

Q26995276-76FECD11-18B0-4450-BE9D-73B65D8BB8E2

P478

Q26995276-29D41759-F441-4754-9B93-FC8E55B70591

P577

Q26995276-7DC1D923-E8A2-4A6A-977E-062D5DC682AC

P5875

Q26995276-B7E69108-71D1-4130-93C3-B159D83BF821

P698

Q26995276-D53D4C96-582B-473A-ABDC-DE6F73A42F18

P921

Q26995276-2D4C6EC2-E8B5-4AB6-A3E0-3E6FB69B0B64

Q26995276-8A8132B8-929A-437B-B3CA-C749DA13C6A2

P932

Q26995276-F4842A38-6D64-4C3D-B813-175AE8A9C29B

P3181

P356

FNEUR.2013.00122

P1433

Frontiers in Neurology

P1476

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

@en

P2093

Adrianne S. Chesser

http://www.w3.org/2001/XMLSchema#string

Gail V. W. Johnson

http://www.w3.org/2001/XMLSchema#string

Susanne M. Pritchard

http://www.w3.org/2001/XMLSchema#string

P2860

Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation

p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy

Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease

Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis

Implications of the serine protease HtrA1 in amyloid precursor protein processing

Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway

Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing

Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo

LC3C, Bound Selectively by a Noncanonical LIR Motif in NDP52, Is Required for Antibacterial Autophagy

Neuropathological stageing of Alzheimer-related changes

P304

122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

954371

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FNEUR.2013.00122

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256502236

http://www.w3.org/2001/XMLSchema#string

P698

24027553

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3759803

http://www.w3.org/2001/XMLSchema#string